alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
Richard A Glennon, Tatiana Bondareva, Richard Young
Pharmacology, Biochemistry, and Behavior October 1, 2006 DOI: 10.1016/j.pbb.2006.09.014 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Drug discrimination study Peer reviewed |
|---|---|
| Population | Male Sprague-Dawley rats |
| Intervention | alpha-Ethyltryptamine (alpha-ET) |
| Dose | 2.5 mg/kg training dose; ED50 values: 1.3 mg/kg (alpha-ET), 1.6 mg/kg (S(-)alpha-ET), 1.3 mg/kg (R(+)alpha-ET), 0.4 mg/kg (DOM), 0.7 mg/kg (PMMA) |
| Duration | 30-min pretreatment time; duration of effect at least 4 h |
| Measures | drug-appropriate responding |
| Key points | alpha-ET produces a complex stimulus that fully generalizes to DOM and PMMA but only partially to amphetamine. |
Abstract
alpha-Ethyltryptamine (etryptamine, alpha-ET) is a drug of abuse that first appeared on the clandestine market in the mid-1980s. Its pharmacological actions are poorly understood. In this investigation, it is reported for the first time that alpha-ET serves as a training drug in drug discrimination studies. Male Sprague-Dawley rats were trained to discriminate (30-min pretreatment time) 2.5 mg/kg of alpha-ET (ED(50)=1.3 mg/kg) from saline vehicle using a standard two-lever operant paradigm and a VI-15s schedule of reinforcement for appetitive reward. Once established, the alpha-ET stimulus was shown to have an onset to action of 30 min and a duration of effect of at least 4 h. In tests of stimulus generalization (substitution), the alpha-ET stimulus generalized to S(-)alpha-ET (ED(50)=1.6 mg/kg) and R(+)alpha-ET (ED(50)=1.3 mg/kg). Tests of stimulus generalization were also conducted with prototypical phenylisopropylamines: (+)amphetamine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), and N-methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA). The alpha-ET stimulus generalized to DOM (ED(50)=0.4 mg/kg) and PMMA (ED(50)=0.7 mg/kg), but only partially generalized (ca. 40% maximal drug-appropriate responding) to (+)amphetamine. The results suggest that alpha-ET produces a complex stimulus.
Citations in the library
Cited by 6
- Toxicology and Analysis of Psychoactive Tryptamines International Journal of Molecular Sciences December 4, 2020
- Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy Journal of Psychopharmacology September 10, 2020
- α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant. ACS Pharmacology & Translational Science December 8, 2023
- Discriminative stimulus properties of α-ethyltryptamine (α-ET) in rats: α-ET-like effects of MDMA, MDA and aryl-monomethoxy substituted derivatives of α-ET. Psychopharmacology June 1, 2025
- Dual Modulation of 5-HT2A Receptors and SERT by α-Ethyltryptamine and Its Optical Isomers. ACS Chemical Neuroscience December 17, 2025
and 1 more in the library
Cites 5
- Discriminative stimulus properties of alpha-ethyltryptamine optical isomers. Pharmacology, Biochemistry, and Behavior 2001
- MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats. Pharmacology, Biochemistry, and Behavior February 1998
- MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM. Pharmacology, Biochemistry, and Behavior October 1993
- Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats. Psychopharmacology 1993
- Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity. Biochemical Pharmacology April 1, 1983